Strategies to increase access to basic sickle cell disease care in low- and middle-income countries.
Meghna DuaHalima Bello-MangaYvonne M CarrollAisha Amal GaladanciUmma Abdulsalam IbrahimAllison Ann KingAyobami OlanrewajuJeremie H EsteppPublished in: Expert review of hematology (2022)
Outcomes for patients with SCD in high-income countries have improved over the last few decades due to the implementation of universal newborn screening programs and use of routine antimicrobial prophylaxis, increase in therapeutic and curative options, and the adoption of specific measures to decrease risk of stroke. This success has not translated to LMICs due to several reasons including resource constraints. A combination of several strategies is needed to increase access to basic SCD care for patients in these settings.
Keyphrases
- sickle cell disease
- healthcare
- quality improvement
- end stage renal disease
- palliative care
- prognostic factors
- ejection fraction
- newly diagnosed
- chronic kidney disease
- primary care
- staphylococcus aureus
- public health
- pain management
- physical activity
- peritoneal dialysis
- type diabetes
- clinical practice
- patient reported outcomes
- metabolic syndrome
- adipose tissue
- weight loss
- patient reported